Loading Page
Dr. Eric Michael Jackson, MD is a neurosurgeon in Baltimore, MD specializing in neurosurgery. He graduated from University of Michigan Medical School in 2002 and has 24 years of experience. Dr. Eric Michael Jackson, MD is affiliated with University of Maryland Medical System and Levi Watkins, Jr., M.D., Outpatient Center.
Dr. Eric Michael Jackson, MD graduated from University of Michigan Medical School in 2002. He completed residency at Hospital of the University of Pennsylvania. He is certified by the American Board of Neurological Surgery - Neurological Surgery and has a state license in Massachusetts.
Medical School: University of Michigan Medical School (2002)
Residency: Hospital of the University of Pennsylvania (2009)
Board Certification: American Board of Neurological Surgery - Neurological Surgery (2014)
Licensed In: Massachusetts
Dr. Eric Michael Jackson, MD does not have any reviews yet, be the first to leave a review of Dr. Eric Michael Jackson, MD here: Leave a Review
These charts describe general payments received by Dr. Eric Michael Jackson, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$2,975
SurgiMend $2,975 |
||
|
$962
None $590 |
MAXFACE $372 |
|
|
$40
VAXNEUVANCE $21 |
VAXELIS $19 |
|
|
$37
PENBRAYA $25 |
TRUMENBA $12 |
|
|
$20
PriMatrix $20 |
| $2,975 | |
| $816 | |
| $242 |
Dr. Eric Jackson specializes in the evaluation and treatment of patients with a broad range of neurosurgical disorders, including congenital malformations of the brain and spine, hydrocephalus (including endoscopic treatment), chiari malformation, craniosynostosis, spinal dysraphism/tethered cord, brain and spinal cord tumors, and traumatic brain injuries. He is the Principal Investigator for several multi-institution research studies, including: Hydrocephalus Clinical Research Network: currently investigating endoscopic surgery vs shunting for the treatment of hydrocephalus in infants in a $10M randomized trial funded by the NIH Park Reeves Syringomyelia Research Consortium Advancing the treatment for pediatric craniopharyngioma, identifying biological targets for molecular therapy A multi-institutional trial investigating a non-invasive eye tracking device for assessing increased intracranial pressure
